La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Analysis of rapid alternating movements in Cree subjects exposed to methylmercury and in subjects with neurological deficits

Identifieur interne : 001148 ( PascalFrancis/Curation ); précédent : 001147; suivant : 001149

Analysis of rapid alternating movements in Cree subjects exposed to methylmercury and in subjects with neurological deficits

Auteurs : A. Beuter [Canada] ; A. De Geoffroy [Canada] ; R. Edwards [Canada]

Source :

RBID : Pascal:99-0196404

Descripteurs français

English descriptors

Abstract

To quantify rapid alternating movements (RAMs) we used a simple prototype developed in our laboratory that requires the subject to rotate two handheld foam spheres connected to optical encoders via flexible rods. Ninety-six participants, including 30 control subjects, 36 Cree subjects exposed to methylmercury, 21 subjects with Parkinson's disease, 6 subjects with cerebellar deficits, and 3 subjects with essential tremor, were involved in the study (though data for 5 were later removed). Twelve characteristics were developed and calculated from the raw data. Conditions examined included two hands at natural cadence (NC2), right and left hands separately at fast cadence (FCl), and both hands at fast cadence (FC2). Two ratios (FC2/NC2) and (FC2/FC1) combining these conditions were also examined. Test-retest reliability was >0.80 for most characteristics but was <0.70 for some characteristics, especially in the conditions executed at normal cadence. Correlations between characteristics and numbers of outliers with respect to the control group distribution were used to reduce the set of characteristics from 12 to 7 (i.e., duration, range, maximum slope, similarity in shape, smoothness, sharpness, and coherence). ANOVAs on the three largest groups generated significant results for most characteristics in the three conditions and the two ratios for Cree subjects and subjects with Parkinson's disease. ANOVAs on 3 age-matched groups (n = 6) suggest that methylmercury affects the performance of the Cree subjects with the higher exposure, especially in terms of smoothness, sharpness, and coherence. These preliminary results suggest that this test is sufficiently specific and sensitive to characterize the performance of different groups of subjects. Ratios tend to improve discrimination for Cree subjects in a few characteristics but not for patients with Parkinson's disease.
pA  
A01 01  1    @0 0013-9351
A02 01      @0 ENVRAL
A03   1    @0 Environ. res. : (NY NY)
A05       @2 80
A06       @2 1
A08 01  1  ENG  @1 Analysis of rapid alternating movements in Cree subjects exposed to methylmercury and in subjects with neurological deficits
A11 01  1    @1 BEUTER (A.)
A11 02  1    @1 DE GEOFFROY (A.)
A11 03  1    @1 EDWARDS (R.)
A14 01      @1 Laboratoire de Neurocinétique, Département de Kinanthropologie, Université du Québec à Montréal, CP 8888, Succursale Centre-ville @2 Montréal, Quebec H3C 3P8 @3 CAN @Z 1 aut. @Z 2 aut. @Z 3 aut.
A14 02      @1 Centre for Nonlinear Dynamics in Physiology and Medicine, McGill University @2 Montréal, Québec @3 CAN @Z 1 aut. @Z 3 aut.
A20       @1 64-79
A21       @1 1999
A23 01      @0 ENG
A43 01      @1 INIST @2 13896 @5 354000073560830080
A44       @0 0000 @1 © 1999 INIST-CNRS. All rights reserved.
A45       @0 8 ref.
A47 01  1    @0 99-0196404
A60       @1 P
A61       @0 A
A64 01  1    @0 Environmental research : (New York, NY)
A66 01      @0 USA
C01 01    ENG  @0 To quantify rapid alternating movements (RAMs) we used a simple prototype developed in our laboratory that requires the subject to rotate two handheld foam spheres connected to optical encoders via flexible rods. Ninety-six participants, including 30 control subjects, 36 Cree subjects exposed to methylmercury, 21 subjects with Parkinson's disease, 6 subjects with cerebellar deficits, and 3 subjects with essential tremor, were involved in the study (though data for 5 were later removed). Twelve characteristics were developed and calculated from the raw data. Conditions examined included two hands at natural cadence (NC2), right and left hands separately at fast cadence (FCl), and both hands at fast cadence (FC2). Two ratios (FC2/NC2) and (FC2/FC1) combining these conditions were also examined. Test-retest reliability was >0.80 for most characteristics but was <0.70 for some characteristics, especially in the conditions executed at normal cadence. Correlations between characteristics and numbers of outliers with respect to the control group distribution were used to reduce the set of characteristics from 12 to 7 (i.e., duration, range, maximum slope, similarity in shape, smoothness, sharpness, and coherence). ANOVAs on the three largest groups generated significant results for most characteristics in the three conditions and the two ratios for Cree subjects and subjects with Parkinson's disease. ANOVAs on 3 age-matched groups (n = 6) suggest that methylmercury affects the performance of the Cree subjects with the higher exposure, especially in terms of smoothness, sharpness, and coherence. These preliminary results suggest that this test is sufficiently specific and sensitive to characterize the performance of different groups of subjects. Ratios tend to improve discrimination for Cree subjects in a few characteristics but not for patients with Parkinson's disease.
C02 01  X    @0 002B03L05
C03 01  X  FRE  @0 Mercure @2 NC @2 FX @5 01
C03 01  X  ENG  @0 Mercury @2 NC @2 FX @5 01
C03 01  X  SPA  @0 Mercurio @2 NC @2 FX @5 01
C03 02  X  FRE  @0 Métal lourd @5 04
C03 02  X  ENG  @0 Heavy metal @5 04
C03 02  X  SPA  @0 Metal pesado @5 04
C03 03  X  FRE  @0 Toxicité @5 07
C03 03  X  ENG  @0 Toxicity @5 07
C03 03  X  SPA  @0 Toxicidad @5 07
C03 04  X  FRE  @0 Trouble neurologique @5 11
C03 04  X  ENG  @0 Neurological disorder @5 11
C03 04  X  SPA  @0 Trastorno neurológico @5 11
C03 05  X  FRE  @0 Trouble motricité @5 13
C03 05  X  ENG  @0 Motility disorder @5 13
C03 05  X  SPA  @0 Trastorno motilidad @5 13
C03 06  X  FRE  @0 Amérindien @5 14
C03 06  X  ENG  @0 Amerindian @5 14
C03 06  X  SPA  @0 Amerindio @5 14
C03 07  X  FRE  @0 Homme @5 16
C03 07  X  ENG  @0 Human @5 16
C03 07  X  SPA  @0 Hombre @5 16
C03 08  X  FRE  @0 Mouvement alternatif @5 17
C03 08  X  ENG  @0 Alternate motion @5 17
C03 08  X  SPA  @0 Movimiento alternativo @5 17
C03 09  X  FRE  @0 Québec @2 NG @5 18
C03 09  X  ENG  @0 Quebec @2 NG @5 18
C03 09  X  SPA  @0 Quebec @2 NG @5 18
C03 10  X  FRE  @0 Test neuropsychologique @5 20
C03 10  X  ENG  @0 Neuropsychological test @5 20
C03 10  X  SPA  @0 Prueba neuropsichologica @5 20
C03 11  X  FRE  @0 Méthode mesure @5 21
C03 11  X  ENG  @0 Measurement method @5 21
C03 11  X  SPA  @0 Método medida @5 21
C03 12  X  FRE  @0 Mouvement corporel @5 22
C03 12  X  ENG  @0 Body movement @5 22
C03 12  X  SPA  @0 Movimiento corporal @5 22
C03 13  X  FRE  @0 Membre supérieur @5 23
C03 13  X  ENG  @0 Upper limb @5 23
C03 13  X  SPA  @0 Miembro superior @5 23
C03 14  X  FRE  @0 Activité manuelle @5 24
C03 14  X  ENG  @0 Manual activity @5 24
C03 14  X  SPA  @0 Actividad manual @5 24
C03 15  X  FRE  @0 Mercure(méthyl) @4 INC @5 86
C07 01  X  FRE  @0 Système nerveux pathologie @5 10
C07 01  X  ENG  @0 Nervous system diseases @5 10
C07 01  X  SPA  @0 Sistema nervioso patología @5 10
C07 02  X  FRE  @0 Canada @2 NG
C07 02  X  ENG  @0 Canada @2 NG
C07 02  X  SPA  @0 Canada @2 NG
C07 03  X  FRE  @0 Amérique du Nord @2 NG
C07 03  X  ENG  @0 North America @2 NG
C07 03  X  SPA  @0 America del norte @2 NG
C07 04  X  FRE  @0 Amérique @2 NG
C07 04  X  ENG  @0 America @2 NG
C07 04  X  SPA  @0 America @2 NG
N21       @1 123

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:99-0196404

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Analysis of rapid alternating movements in Cree subjects exposed to methylmercury and in subjects with neurological deficits</title>
<author>
<name sortKey="Beuter, A" sort="Beuter, A" uniqKey="Beuter A" first="A." last="Beuter">A. Beuter</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Laboratoire de Neurocinétique, Département de Kinanthropologie, Université du Québec à Montréal, CP 8888, Succursale Centre-ville</s1>
<s2>Montréal, Quebec H3C 3P8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Centre for Nonlinear Dynamics in Physiology and Medicine, McGill University</s1>
<s2>Montréal, Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="De Geoffroy, A" sort="De Geoffroy, A" uniqKey="De Geoffroy A" first="A." last="De Geoffroy">A. De Geoffroy</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Laboratoire de Neurocinétique, Département de Kinanthropologie, Université du Québec à Montréal, CP 8888, Succursale Centre-ville</s1>
<s2>Montréal, Quebec H3C 3P8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Edwards, R" sort="Edwards, R" uniqKey="Edwards R" first="R." last="Edwards">R. Edwards</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Laboratoire de Neurocinétique, Département de Kinanthropologie, Université du Québec à Montréal, CP 8888, Succursale Centre-ville</s1>
<s2>Montréal, Quebec H3C 3P8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Centre for Nonlinear Dynamics in Physiology and Medicine, McGill University</s1>
<s2>Montréal, Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">99-0196404</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0196404 INIST</idno>
<idno type="RBID">Pascal:99-0196404</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D75</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001148</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Analysis of rapid alternating movements in Cree subjects exposed to methylmercury and in subjects with neurological deficits</title>
<author>
<name sortKey="Beuter, A" sort="Beuter, A" uniqKey="Beuter A" first="A." last="Beuter">A. Beuter</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Laboratoire de Neurocinétique, Département de Kinanthropologie, Université du Québec à Montréal, CP 8888, Succursale Centre-ville</s1>
<s2>Montréal, Quebec H3C 3P8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Centre for Nonlinear Dynamics in Physiology and Medicine, McGill University</s1>
<s2>Montréal, Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="De Geoffroy, A" sort="De Geoffroy, A" uniqKey="De Geoffroy A" first="A." last="De Geoffroy">A. De Geoffroy</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Laboratoire de Neurocinétique, Département de Kinanthropologie, Université du Québec à Montréal, CP 8888, Succursale Centre-ville</s1>
<s2>Montréal, Quebec H3C 3P8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Edwards, R" sort="Edwards, R" uniqKey="Edwards R" first="R." last="Edwards">R. Edwards</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Laboratoire de Neurocinétique, Département de Kinanthropologie, Université du Québec à Montréal, CP 8888, Succursale Centre-ville</s1>
<s2>Montréal, Quebec H3C 3P8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Centre for Nonlinear Dynamics in Physiology and Medicine, McGill University</s1>
<s2>Montréal, Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Environmental research : (New York, NY)</title>
<title level="j" type="abbreviated">Environ. res. : (NY NY)</title>
<idno type="ISSN">0013-9351</idno>
<imprint>
<date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Environmental research : (New York, NY)</title>
<title level="j" type="abbreviated">Environ. res. : (NY NY)</title>
<idno type="ISSN">0013-9351</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Alternate motion</term>
<term>Amerindian</term>
<term>Body movement</term>
<term>Heavy metal</term>
<term>Human</term>
<term>Manual activity</term>
<term>Measurement method</term>
<term>Mercury</term>
<term>Motility disorder</term>
<term>Neurological disorder</term>
<term>Neuropsychological test</term>
<term>Quebec</term>
<term>Toxicity</term>
<term>Upper limb</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Mercure</term>
<term>Métal lourd</term>
<term>Toxicité</term>
<term>Trouble neurologique</term>
<term>Trouble motricité</term>
<term>Amérindien</term>
<term>Homme</term>
<term>Mouvement alternatif</term>
<term>Québec</term>
<term>Test neuropsychologique</term>
<term>Méthode mesure</term>
<term>Mouvement corporel</term>
<term>Membre supérieur</term>
<term>Activité manuelle</term>
<term>Mercure(méthyl)</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Mercure</term>
<term>Métal lourd</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">To quantify rapid alternating movements (RAMs) we used a simple prototype developed in our laboratory that requires the subject to rotate two handheld foam spheres connected to optical encoders via flexible rods. Ninety-six participants, including 30 control subjects, 36 Cree subjects exposed to methylmercury, 21 subjects with Parkinson's disease, 6 subjects with cerebellar deficits, and 3 subjects with essential tremor, were involved in the study (though data for 5 were later removed). Twelve characteristics were developed and calculated from the raw data. Conditions examined included two hands at natural cadence (NC2), right and left hands separately at fast cadence (FCl), and both hands at fast cadence (FC2). Two ratios (FC2/NC2) and (FC2/FC1) combining these conditions were also examined. Test-retest reliability was >0.80 for most characteristics but was <0.70 for some characteristics, especially in the conditions executed at normal cadence. Correlations between characteristics and numbers of outliers with respect to the control group distribution were used to reduce the set of characteristics from 12 to 7 (i.e., duration, range, maximum slope, similarity in shape, smoothness, sharpness, and coherence). ANOVAs on the three largest groups generated significant results for most characteristics in the three conditions and the two ratios for Cree subjects and subjects with Parkinson's disease. ANOVAs on 3 age-matched groups (n = 6) suggest that methylmercury affects the performance of the Cree subjects with the higher exposure, especially in terms of smoothness, sharpness, and coherence. These preliminary results suggest that this test is sufficiently specific and sensitive to characterize the performance of different groups of subjects. Ratios tend to improve discrimination for Cree subjects in a few characteristics but not for patients with Parkinson's disease.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0013-9351</s0>
</fA01>
<fA02 i1="01">
<s0>ENVRAL</s0>
</fA02>
<fA03 i2="1">
<s0>Environ. res. : (NY NY)</s0>
</fA03>
<fA05>
<s2>80</s2>
</fA05>
<fA06>
<s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Analysis of rapid alternating movements in Cree subjects exposed to methylmercury and in subjects with neurological deficits</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>BEUTER (A.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>DE GEOFFROY (A.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>EDWARDS (R.)</s1>
</fA11>
<fA14 i1="01">
<s1>Laboratoire de Neurocinétique, Département de Kinanthropologie, Université du Québec à Montréal, CP 8888, Succursale Centre-ville</s1>
<s2>Montréal, Quebec H3C 3P8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Centre for Nonlinear Dynamics in Physiology and Medicine, McGill University</s1>
<s2>Montréal, Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA20>
<s1>64-79</s1>
</fA20>
<fA21>
<s1>1999</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>13896</s2>
<s5>354000073560830080</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 1999 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>8 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>99-0196404</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Environmental research : (New York, NY)</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>To quantify rapid alternating movements (RAMs) we used a simple prototype developed in our laboratory that requires the subject to rotate two handheld foam spheres connected to optical encoders via flexible rods. Ninety-six participants, including 30 control subjects, 36 Cree subjects exposed to methylmercury, 21 subjects with Parkinson's disease, 6 subjects with cerebellar deficits, and 3 subjects with essential tremor, were involved in the study (though data for 5 were later removed). Twelve characteristics were developed and calculated from the raw data. Conditions examined included two hands at natural cadence (NC2), right and left hands separately at fast cadence (FCl), and both hands at fast cadence (FC2). Two ratios (FC2/NC2) and (FC2/FC1) combining these conditions were also examined. Test-retest reliability was >0.80 for most characteristics but was <0.70 for some characteristics, especially in the conditions executed at normal cadence. Correlations between characteristics and numbers of outliers with respect to the control group distribution were used to reduce the set of characteristics from 12 to 7 (i.e., duration, range, maximum slope, similarity in shape, smoothness, sharpness, and coherence). ANOVAs on the three largest groups generated significant results for most characteristics in the three conditions and the two ratios for Cree subjects and subjects with Parkinson's disease. ANOVAs on 3 age-matched groups (n = 6) suggest that methylmercury affects the performance of the Cree subjects with the higher exposure, especially in terms of smoothness, sharpness, and coherence. These preliminary results suggest that this test is sufficiently specific and sensitive to characterize the performance of different groups of subjects. Ratios tend to improve discrimination for Cree subjects in a few characteristics but not for patients with Parkinson's disease.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B03L05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Mercure</s0>
<s2>NC</s2>
<s2>FX</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Mercury</s0>
<s2>NC</s2>
<s2>FX</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Mercurio</s0>
<s2>NC</s2>
<s2>FX</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Métal lourd</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Heavy metal</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Metal pesado</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Toxicité</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Toxicity</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Toxicidad</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Trouble motricité</s0>
<s5>13</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Motility disorder</s0>
<s5>13</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Trastorno motilidad</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Amérindien</s0>
<s5>14</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Amerindian</s0>
<s5>14</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Amerindio</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Homme</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Human</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>16</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Mouvement alternatif</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Alternate motion</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Movimiento alternativo</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Québec</s0>
<s2>NG</s2>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Quebec</s0>
<s2>NG</s2>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Quebec</s0>
<s2>NG</s2>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Test neuropsychologique</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Neuropsychological test</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Prueba neuropsichologica</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Méthode mesure</s0>
<s5>21</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Measurement method</s0>
<s5>21</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Método medida</s0>
<s5>21</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Mouvement corporel</s0>
<s5>22</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Body movement</s0>
<s5>22</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Movimiento corporal</s0>
<s5>22</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE">
<s0>Membre supérieur</s0>
<s5>23</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG">
<s0>Upper limb</s0>
<s5>23</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA">
<s0>Miembro superior</s0>
<s5>23</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE">
<s0>Activité manuelle</s0>
<s5>24</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG">
<s0>Manual activity</s0>
<s5>24</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA">
<s0>Actividad manual</s0>
<s5>24</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE">
<s0>Mercure(méthyl)</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>10</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>10</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>10</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Canada</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Canada</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Canada</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Amérique du Nord</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>North America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>America del norte</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Amérique</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>America</s0>
<s2>NG</s2>
</fC07>
<fN21>
<s1>123</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001148 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001148 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:99-0196404
   |texte=   Analysis of rapid alternating movements in Cree subjects exposed to methylmercury and in subjects with neurological deficits
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022